ORCHARD THERAPEUTICS PLC Shareholders' Equity
ORCHARD THERAPEUTICS PLC had Shareholders' Equity of $80.26 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-11-13
- 2023-09-30: Stockholders' Equity Attributable to Parent $80.26M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $109.05M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $101.66M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $98.26M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-09-30 | $80.26M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $109.05M 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $101.66M 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $98.26M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $123.70M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $146.27M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $175.65M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $209.95M 10-Q · filed 2023-11-13 | |
| 2021-09-30 | $241.30M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $264.37M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $295.58M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $178.43M 10-K · filed 2023-03-14 | |
| 2020-09-30 | $207.07M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $227.02M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $264.55M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $299.19M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $339.74M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $371.16M 10-Q · filed 2020-11-03 | |
| 2019-03-31 | $287.48M 10-Q · filed 2020-11-03 | $287.48M 6-K · filed 2019-05-28 |
| 2018-12-31 | $311.34M 10-K · filed 2021-03-02 | |
| 2017-12-31 | $86.41M 20-F · filed 2019-03-22 |